טוען...
AC-186, a Selective Nonsteroidal Estrogen Receptor β Agonist, Shows Gender Specific Neuroprotection in a Parkinson’s Disease Rat Model
[Image: see text] Drugs that selectively activate estrogen receptor β (ERβ) are potentially safer than the nonselective estrogens currently used in hormonal replacement treatments that activate both ERβ and ERα. The selective ERβ agonist AC-186 was evaluated in a rat model of Parkinson’s disease ind...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American
Chemical Society
2013
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3778431/ https://ncbi.nlm.nih.gov/pubmed/23898966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn400132u |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|